Back

Impact of age at the time of the first ST-elevation myocardial infarction on 10-year outcomes. A sub-analysis from the EXAMINATION EXTEND trial

27 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: STEMI Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Victor Andres Arevalos Rivas

Hospital Clinic of Barcelona, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
The vascular response to ultrathin biodegradable polymer sirolimus-eluting stent at 2-weeks and 1-year follow up in patients with ST-elevation myocardial infarction
Doctor Y. Oishi (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Reperfusion strategy and late clinical outcomes of patients with ST-elevation myocardial infarction (STEMI) in the absence of standard modifiable risk factors (SMuRFs)
Professor J. French (Sydney, AU)
Abstract Slides
Presentation thumbnail
Deferred stent implantation in patients with ST segment elevation myocardial infarction with high thrombus burden
Doctor M. Mohamady (Benha, EG)
Abstract Slides
Presentation thumbnail
Predictors of no-reflow in patients with myocardial infarction and ST-segment elevation treated with primary angioplasty
Doctor A. Cordero (Alicante, ES)
Abstract Slides
Presentation thumbnail
All-cause mortality of patients with STEMI, cardiogenic shock and multivessel coronary disease treated with culprit vessel only versus multivessel primary PCI.
Doctor O. Hlinomaz (Brno, CZ)
Abstract Slides

Access the full session

Session thumbnail
STEMI

The Event

Event poster

ESC Congress 2022

27 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of percutaneous coronary intervention on improvement of left ventricular ejection fraction among chronic coronary syndrome patients with left ventricular systolic dysfunction
thumbnail
Congress Presentation
Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Percutaneous coronary intervention versus optimal medical therapy for chronic total occlusion: an updated meta-analysis of randomized controlled trials comparing clinical and health status outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources